Robbert Slebos
Faculty Member
Last active: 3/12/2014


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Application of genomic and proteomic technologies in biomarker discovery. Fertig EJ, Slebos R, Chung CH (2012) Am Soc Clin Oncol Educ Book : 377-82
    › Primary publication · 24451767 (PubMed)
  2. Proteogenomic analysis reveals unanticipated adaptations of colorectal tumor cells to deficiencies in DNA mismatch repair. Halvey PJ, Wang X, Wang J, Bhat AA, Dhawan P, Li M, Zhang B, Liebler DC, Slebos RJ (2014) Cancer Res 74(1): 387-97
    › Primary publication · 24247723 (PubMed) · PMC3896054 (PubMed Central)
  3. Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma. Husain H, Psyrri A, Markovic A, Rampias T, Pectasides E, Wang H, Slebos R, Yarbrough WG, Burtness B, Chung CH (2012) Laryngoscope 122(12): 2762-8
    › Primary publication · 23086695 (PubMed) · PMC3574977 (PubMed Central)
  4. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers. Kikuchi T, Hassanein M, Amann JM, Liu Q, Slebos RJ, Rahman SM, Kaufman JM, Zhang X, Hoeksema MD, Harris BK, Li M, Shyr Y, Gonzalez AL, Zimmerman LJ, Liebler DC, Massion PP, Carbone DP (2012) Mol Cell Proteomics 11(10): 916-32
    › Primary publication · 22761400 (PubMed) · PMC3494148 (PubMed Central)
  5. Proteomic analysis of oropharyngeal carcinomas reveals novel HPV-associated biological pathways. Slebos RJ, Jehmlich N, Brown B, Yin Z, Chung CH, Yarbrough WG, Liebler DC (2013) Int J Cancer 132(3): 568-79
    › Primary publication · 22733545 (PubMed) · PMC3479311 (PubMed Central)
  6. A Reporter System for Translational Readthrough of Stop Codons in Human Cells. Halvey PJ, Liebler DC, Slebos RJ (2012) FEBS Open Bio : 56-59
    › Primary publication · 22563532 (PubMed) · PMC3342693 (PubMed Central)
  7. Global stability of plasma proteomes for mass spectrometry-based analyses. Zimmerman LJ, Li M, Yarbrough WG, Slebos RJ, Liebler DC (2012) Mol Cell Proteomics 11(6): M111.014340
    › Primary publication · 22301387 (PubMed) · PMC3433892 (PubMed Central)
  8. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, Tsukamoto T, Rojas CJ, Slusher BS, Zhang H, Zimmerman LJ, Liebler DC, Slebos RJ, Lorkiewicz PK, Higashi RM, Fan TW, Dang CV (2012) Cell Metab 15(1): 110-21
    › Primary publication · 22225880 (PubMed) · PMC3345194 (PubMed Central)
  9. Protein identification using customized protein sequence databases derived from RNA-Seq data. Wang X, Slebos RJ, Wang D, Halvey PJ, Tabb DL, Liebler DC, Zhang B (2012) J Proteome Res 11(2): 1009-17
    › Primary publication · 22103967 (PubMed) · PMC3727138 (PubMed Central)
  10. Proteomic consequences of a single gene mutation in a colorectal cancer model. Halvey PJ, Zhang B, Coffey RJ, Liebler DC, Slebos RJ (2012) J Proteome Res 11(2): 1184-95
    › Primary publication · 22103262 (PubMed) · PMC3271737 (PubMed Central)
  11. Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer. Gilbert J, Murphy B, Dietrich MS, Henry E, Jordan R, Counsell A, Wirth P, Yarbrough WG, Slebos RJ, Chung CH (2012) Cancer 118(4): 1007-13
    › Primary publication · 21766301 (PubMed)
  12. A bioinformatics workflow for variant peptide detection in shotgun proteomics. Li J, Su Z, Ma ZQ, Slebos RJ, Halvey P, Tabb DL, Liebler DC, Pao W, Zhang B (2011) Mol Cell Proteomics 10(5): M110.006536
    › Primary publication · 21389108 (PubMed) · PMC3098595 (PubMed Central)
  13. Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry. Zhang H, Liu Q, Zimmerman LJ, Ham AJ, Slebos RJ, Rahman J, Kikuchi T, Massion PP, Carbone DP, Billheimer D, Liebler DC (2011) Mol Cell Proteomics 10(6): M110.006593
    › Primary publication · 21357624 (PubMed) · PMC3108838 (PubMed Central)